Parallel Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

Parallel Advisors’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8	Closed	–	–	3601
2022 Q3	$0	Buy	+8	New	+$93	﹤0.01%	3629
2021 Q4	–	Sell	-302	Closed	-$3.16K	–	3402
2021 Q3	$3K	Buy	+302	New	+$4.42K	﹤0.01%	2624

Parallel Advisors's AERI Position: Q4 2022 in Review

Parallel Advisors sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 8 shares.

Parallel Advisors first reported a position in AERI in Q3 2021 and held it in 2 quarters. The position peaked at $3K in Q3 2021. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Parallel Advisors reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Parallel Advisors sold 8 Aerie Pharmaceuticals shares in Q4 2022.
Parallel Advisors first reported a position in Aerie Pharmaceuticals in Q3 2021 and held it in 2 quarters.
Parallel Advisors's Aerie Pharmaceuticals position peaked at $3K in Q3 2021.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Parallel Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.